Menü
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Humana Military Names Alefiyah Mesiwala, M.D., Chief Medical Officer
Humana Military Names Alefiyah Mesiwala, M.D., Chief Medical Officer


Humana Military, a wholly owned subsidiary of Humana Inc. (NYSE: HUM), announced today the appointment of Alefiyah Mesiwala, M.D., MPH, as Humana Military’s new Chief Medical Officer. Effective

Acadia Healthcare to Participate in Raymond James 42nd Annual Institutional Investors Conference: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare to Participate in Raymond James 42nd Annual Institutional Investors Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Raymond James 42nd Annual Institutional Investors Conference, which is being held as a

Mercy and Humana Team Up to Expand Access to Virtual Health Services and Coordinated Care: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Mercy and Humana Team Up to Expand Access to Virtual Health Services and Coordinated Care


Missouri-based Mercy and leading health and well-being company Humana Inc. (NYSE: HUM) have signed an agreement to expand patient access to virtual health resources as part of a broader, joint

STAAR Surgical Reports Fourth Quarter and Full Year 2020 Results: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Reports Fourth Quarter and Full Year 2020 Results


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the

Ethisphere® Institute Recognizes Premier Inc. as One of the 2021 World’s Most Ethical Companies® for the 14th Year in a Row: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Ethisphere® Institute Recognizes Premier Inc. as One of the 2021 World’s Most Ethical Companies® for the 14th Year in a Row


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has been named one of the 2021 World’s Most Ethical Companies by the Ethisphere® Institute, a global leader in defining and

Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link: https://mms.businesswire.com/media/20191105005256/en/560437/5/Waters_logo_K.jpg
Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link


Waters Corporation (NYSE:WAT) today announced it has entered a reseller agreement with TetraScience, a cloud technology innovator powering transformational changes in life sciences R&D. Through the

NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a

LivaNova Reports Fourth Quarter and Full-Year 2020 Results: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Reports Fourth Quarter and Full-Year 2020 Results


LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2020.



For the fourth quarter of

Chemed Reports Fourth-Quarter 2020 Results
Chemed Reports Fourth-Quarter 2020 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS)

PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening


PerkinElmer, Inc. (NYSE: PKI) today announced the launch of the PerkinElmer® COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or

Quidel to Present at Upcoming Conferences
Quidel to Present at Upcoming Conferences


Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at

Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)


Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC 22C3 pharmDx assay for expanded use in patients with

PerkinElmer Provides an Update on Valencia Branch Laboratory’s Accreditation Process: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer Provides an Update on Valencia Branch Laboratory’s Accreditation Process


PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today provided an update on the COVID-19 Valencia Branch Laboratory’s (VBL) accreditation process. The

NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the Whole

Chemed Corporation Declares Quarterly Dividend of 34 Cents
Chemed Corporation Declares Quarterly Dividend of 34 Cents


Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 34-cents per share on the Company’s capital stock, payable on March 19, 2021, to

Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases
Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases


February 19, 2021 -- Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the

Agilent Ranks No. 2 on Barron’s List of America’s Most Sustainable Companies
Agilent Ranks No. 2 on Barron’s List of America’s Most Sustainable Companies


Agilent Technologies Inc. (NYSE: A) has earned the number two position on Barron’s annual list of America’s Most Sustainable Companies. The ranking marks the third straight year Agilent has been

Quidel Reports Fourth Quarter and Full Year 2020 Financial Results
Quidel Reports Fourth Quarter and Full Year 2020 Financial Results


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the

AMN Healthcare Announces Fourth Quarter and Full Year 2020 Results
AMN Healthcare Announces Fourth Quarter and Full Year 2020 Results


AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year

Premier Inc. to Participate in 10th Annual SVB Leerink Global Healthcare Conference on February 24, 2021: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. to Participate in 10th Annual SVB Leerink Global Healthcare Conference on February 24, 2021


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to present at the 10th Annual SVB Leerink Global Healthcare

Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies
Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies


Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of

Dexcom Announces Upcoming Virtual Conference Presentations: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Virtual Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences:




  • Quentin Blackford, Chief Operating

Humana Launches Humana Care Support Pilot to Help Medicare Advantage Members to Better Manage Their Chronic Conditions: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Launches Humana Care Support Pilot to Help Medicare Advantage Members to Better Manage Their Chronic Conditions


Humana Inc. (NYSE: HUM) recently launched a pilot for its new Humana Care Support, formerly known as the Enterprise Clinical Operating Model (ECOM), to help support a select group of Medicare